Barron's |
JNJ Diabetes Data Benefit Lilly, Hurt Merck
Barron's Our conversations with experts at the American Diabetes Association (ADA) suggest many feel this may in fact be a class effect, potentially related to volume depletion in patients who have a history of peripheral artery disease or prior amputation. The ... Diabetes Drug Invokana Makes Promising Progress New drug shows promise for treating heart disease in diabetes patients Diabetes drug helps hearts too |
Social Plugin